There’s a different equity story being told by sentiment: Zentalis Pharmaceuticals Inc. (ZNTL).

The closing price of Zentalis Pharmaceuticals Inc. (NASDAQ: ZNTL) was $26.74 for the day, down -2.05% from the previous closing price of $27.30. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 888689 shares were traded. ZNTL stock price reached its highest trading level at $27.45 during the session, while it also had its lowest trading level at $25.75.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



Our analysis of ZNTL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.00 and its Current Ratio is at 8.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 14 when Gallagher Cam sold 8,501 shares for $19.96 per share. The transaction valued at 169,706 led to the insider holds 491,270 shares of the business.

Bunker Kevin D. sold 6,500 shares of ZNTL for $129,873 on Feb 14. The Chief Scientific Officer now owns 865,157 shares after completing the transaction at $19.98 per share. On Feb 14, another insider, Epperly Melissa B, who serves as the Chief Financial Officer of the company, sold 5,227 shares for $19.98 each. As a result, the insider received 104,411 and left with 392,048 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 1.60B and an Enterprise Value of 1.21B.

Stock Price History:

Over the past 52 weeks, ZNTL has reached a high of $32.34, while it has fallen to a 52-week low of $15.55. The 50-Day Moving Average of the stock is 20.78, while the 200-Day Moving Average is calculated to be 22.06.

Shares Statistics:

ZNTL traded an average of 656.80K shares per day over the past three months and 884.04k shares per day over the past ten days. A total of 58.13M shares are outstanding, with a floating share count of 52.72M. Insiders hold about 2.80% of the company’s shares, while institutions hold 109.09% stake in the company. Shares short for ZNTL as of Apr 27, 2023 were 9.83M with a Short Ratio of 9.83M, compared to 8.9M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 16.55% and a Short% of Float of 22.21%.

Earnings Estimates

The firm’s stock currently is rated by 10 analysts. On average, analysts expect EPS of -$1.04 for the current quarter, with a high estimate of -$0.91 and a low estimate of -$1.15, while EPS last year was -$1.34. The consensus estimate for the next quarter is -$1.05, with high estimates of -$0.92 and low estimates of -$1.21.

Analysts are recommending an EPS of between -$3.81 and -$4.6 for the fiscal current year, implying an average EPS of -$4.26. EPS for the following year is -$4.4, with 11 analysts recommending between -$3.57 and -$5.8.